Stimulant Treatment of ADHD and Cigarette Smoking: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: Individuals with attention-deficit/hyperactivity disorder (ADHD) have a significantly higher risk of cigarette smoking. The nature of the relationship between smoking and psychostimulant medications commonly used to treat ADHD is controversial. Our objective was to examine the relationship between stimulant treatment of ADHD and cigarette smoking by using meta-analysis, and to identify study and sample characteristics that moderate this relationship. METHODS: Literature searches on PubMed and PsycInfo databases identified published studies for inclusion. Included studies compared cigarette smoking outcomes for stimulant-treated and untreated ADHD individuals. Seventeen studies met inclusion criteria, and 14 (total n = 2360) contained sufficient statistical information for inclusion in the meta-analysis. Two authors extracted odds ratios or frequencies of smokers in the treatment or nontreatment groups, and coded study characteristics including sample source, percentage of male participants, follow-up length, treatment consistency, type of smoking measure, prospective study, and controlling for comorbidities. RESULTS: Meta-analysis revealed a significant association between stimulant treatment and lower smoking rates. Meta-regression indicated that effect sizes were larger for studies that used clinical samples, included more women, measured smoking in adolescence rather than adulthood, conceptualized stimulant treatment as consistent over time, and accounted for comorbid conduct disorder. CONCLUSIONS: Nearly all studies were naturalistic, precluding causal inferences. Available data were insufficient to examine additional influences of patient demographics, treatment effectiveness, or other comorbidities. Consistent stimulant treatment of ADHD may reduce smoking risk; the effect was larger in samples with more severe psychopathology. Implications for further research, treatment of ADHD, and smoking prevention are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A meta-analysis of 14 studies with over 2,300 participants found that people with ADHD were about half as likely to smoke cigarettes when regularly treated with stimulant medications (Schoenfelder et al., 2014).”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Schoenfelder et al., 2014
In the citing paper
“substantial literature that indicates stimulant use in childhood has a protective effect on subsequent smoking 171”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [171]
In the citing paper
“Methylphenidate is a stimulant commonly used to treat ADHD, and in adolescents, methylphenidate was also shown to reduce smoking (Hammerness et al., 2013; Schoenfelder, Faraone, & Kollins, 2014).”
From Nicotine addiction and psychiatric disorders (2015) · cites this paper as Schoenfelder, Faraone, & Kollins, 2014
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
(2014) · Medical Entomology and Zoology · Cited by 17,633
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Self-citationTanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23d0 · Cited by 1,182
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.01.006 · Cited by 875
Froehlich, T. E., Lanphear, B. P., Epstein, J. N., Barbaresi, W. J., Katusic, S. K., & Kahn, R. S. (2007) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.161.9.857 · Cited by 794
Current Cigarette Smoking Among Adults—United States, 2011
(2013) · JAMA · doi:10.1001/jama.2012.114523 · Cited by 769
Research works printed but not linked: 2
- Lee, 2011, Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review., Clin Psychol Rev, 31, 328, 10.1016/j.cpr.2011.01.006 · DOI · Paper page
- Flory, 2011, Childhood ADHD symptoms and risk for cigarette smoking during adolescence: school adjustment as a potential mediator., Psychol Addict Behav, 25, 320, 10.1037/a0022633 · DOI
Cited by
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545
“meta-analysis of 14 studies with over 2300 participants found that people with ADHD were about half as likely to smoke cigarettes when regularly treated with stimulant medications (Schoenfelder et al., 2014).”
Self-citationAttention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Self-citationChildhood Psychiatric Disorders as Risk Factor for Subsequent Substance Abuse: A Meta-Analysis.
Groenman, A. P., Janssen, T. W. P., & Oosterlaan, J. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.05.004 · Cited by 335
Misuse of Stimulant Medication Among College Students: A Comprehensive Review and Meta-analysis
Benson, K., Flory, K., Humphreys, K. L., & Lee, S. S. (2015) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-014-0177-z · Cited by 328
“…not increase risk for substance use disorders (Humphreys et al. 2013) and the use of stimulant medication to treat ADHD may even reduce drug use (Schoenfelder et al. 2014), a preponderance of existing research suggests that ADHD is a risk factor for substance use in general (Gudjonsson et al.…”
BackgroundPollak, Y., Dekkers, T. J., Shoham, R., & Huizenga, H. M. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1019-y · Cited by 165
ADHD Pharmacotherapy and Mortality in Individuals With ADHD
Li, L., Zhu, N., Zhang, L., Kuja-Halkola, R., D’Onofrio, B. M., Brikell, I., Lichtenstein, P., Cortese, S., Larsson, H., & Chang, Z. (2024) · JAMA · doi:10.1001/jama.2024.0851 · Cited by 124
A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder
Chaulagain, A., Lyhmann, I., Halmøy, A., Widding‐Havneraas, T., Nyttingnes, O., Bjelland, I., & Mykletun, A. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2451 · Cited by 111
Man, K. K. C., Häge, A., Banaschewski, T., Inglis, S. K., Buitelaar, J. K., Carucci, S., Danckaerts, M., Dittmann, R., Falissard, B., Garas, P., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00042-1 · Cited by 99
Topical Review: ADHD and Health-Risk Behaviors: Toward Prevention and Health Promotion
Schoenfelder, E. N., & Kollins, S. H. (2015) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsv162 · Cited by 82
Self-citationCausal Factors of Increased Smoking in ADHD: A Systematic Review
van Amsterdam, J., van der Velde, B., Schulte, M., & van den Brink, W. (2018) · Substance Use & Misuse · doi:10.1080/10826084.2017.1334066 · Cited by 67
“According to Schoenfelder et al. (2014) the variation in outcome of epidemiological studies may be explained by the larger effect sizes that are obtained in studies which used clinical samples, included relatively more females and measured smoking in adolescence rather than adulthood.”
ResultNicotine addiction and psychiatric disorders
Kutlu, M. G., Parikh, V., & Gould, T. J. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.08.004 · Cited by 65
Links Between Child and Adolescent Psychiatric Disorders and Cardiovascular Risk
Goldstein, B. I., & Korczak, D. J. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.06.023 · Cited by 55
Zhang‐James, Y., Chen, Q., Kuja‐Halkola, R., Lichtenstein, P., Larsson, H., & Faraone, S. V. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13226 · Cited by 47
“…of ADHD in youth leads to lower risks for outcomes such as criminality (Lichtenstein et al., 2012), traffic accidents (Chang, Lichtenstein, D’Onofrio, Sjolander, & Larsson, 2014), smoking (Schoenfelder et al., 2014), and SUDs (Chang, Lichtenstein, Halldner, et al., 2014; Quinn et al., 2017).”
BackgroundSelf-citationGroenman, A. P., Schweren, L. J. S., Dietrich, A., & Hoekstra, P. J. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1301928 · Cited by 46
“While one meta-analysis reported a protective effect of stimulant treatment on the development of tobacco use [76], the other found that stimulant treatment did not”
ResultRhodes, J. D., Pelham, W. E., Gnagy, E. M., Shiffman, S., Derefinko, K. J., & Molina, B. S. G. (2016) · Psychology of Addictive Behaviors · doi:10.1037/adb0000188 · Cited by 43
Addressing Adolescents’ and Young Adults’ Substance Use Disorders
Chadi, N., Bagley, S. M., & Hadland, S. E. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.015 · Cited by 44
Mattingly, G. W., Wilson, J. A., Ugarte, L., & Glaser, P. E. A. (2020) · CNS Spectrums · doi:10.1017/s1092852919001822 · Cited by 50
Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.
Molina, B. S. G., Kennedy, T. M., Howard, A. L., Swanson, J. M., Arnold, L. E., Mitchell, J. T., Stehli, A., Kennedy, E. H., Epstein, J. N., Hechtman, L. T., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.2157 · Cited by 42
Groenman, A. P., Schweren, L. J. S., Weeda, W., Luman, M., Noordermeer, S. D. S., Heslenfeld, D. J., Franke, B., Faraone, S. V., Rommelse, N., Hartman, C. A., et al. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01283-y · Cited by 36
Self-citationIncreased Risk of Smoking in Female Adolescents Who Had Childhood ADHD
Elkins, I. J., Saunders, G. R. B., Malone, S. M., Keyes, M. A., Samek, D. R., McGue, M., & Iacono, W. G. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17010009 · Cited by 33
Neurobiology of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Radonjić, N. V. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_33-1 · Cited by 35
Self-citationMitchell, J. T., Howard, A. L., Belendiuk, K. A., Kennedy, T. M., Stehli, A., Swanson, J. M., Hechtman, L. T., Arnold, L. E., Hoza, B., Vitiello, B., et al. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty045 · Cited by 41
Self-citationHoward, A. L., Kennedy, T. M., Mitchell, J. T., Sibley, M. H., Hinshaw, S. P., Arnold, L. E., Roy, A., Stehli, A., Swanson, J. M., & Molina, B. S. G. (2020) · Psychology of Addictive Behaviors · doi:10.1037/adb0000542 · Cited by 34
Approach to Evaluating and Managing Adult Attention-Deficit/Hyperactivity Disorder in Primary Care
Huang, H. Y., Huang, H., Spottswood, M., & Ghaemi, S. N. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000248 · Cited by 28
Attention Deficit Hyperactivity Disorder and Substance Use Disorder: A Narrative Review
Srichawla, B. S., Telles, C. C., Schweitzer, M., & Darwish, B. (2022) · Cureus · doi:10.7759/cureus.24068 · Cited by 33
“A similar study found some evidence that effective ADHD treatment can help prevent cigarette smoking [48].”
BackgroundZahlan, L., Ghandour, L. A., Yassin, N., Afifi, R., & Martins, S. S. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.020 · Cited by 17
Research Brief: The Teen ADHD Workshop to Improve Adolescent ADHD Treatment Engagement
Schoenfelder, E. N., McCabe, C. J., Fife, A., Herzig, L., & Ahrens, K. R. (2017) · Journal of Attention Disorders · doi:10.1177/1087054716686184 · Cited by 14
Self-citationCorona, R., Dvorsky, M. R., Romo, S., Parks, A. M., Bourchtein, E., Smith, Z. R., Avila, M., & Langberg, J. M. (2020) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-020-00689-6 · Cited by 15
Peters, M. S., Park, C. H. J., Turner, A., Guerin, A. A., & Kim, J. H. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100064 · Cited by 11
Tobacco and ADHD: A Role of MAO-Inhibition in Nicotine Dependence and Alleviation of ADHD Symptoms
Taylor, M. R., Carrasco, K., Carrasco, A. E., & Basu, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.845646 · Cited by 13
Namimi‐Halevi, C., Dor, C., Dichtiar, R., Bromberg, M., & Sinai, T. (2024) · Public Health · doi:10.1016/j.puhe.2024.08.029 · Cited by 11
The overlapping neurobiology of addiction and ADHD
Eme, R. F. (2017) · Mental Health and Addiction Research · doi:10.15761/mhar.1000129 · Cited by 14
“Thus adolescents who are prone to risky substance use “may seek the more extreme reward of drugs because their experience of conventional rewards is blunted” [21].”
BackgroundAssessment and Treatment of Attention-Deficit/Hyperactivity Disorder: Part 1
French, W. P. (2015) · Pediatric Annals · doi:10.3928/00904481-20150313-13 · Cited by 9
Skutle, A., Bu, E. T. H., Jellestad, F. K., Oortmerssen, K. V. E., Dom, G., Verspreet, S., Carpentier, P. J., Ramos‐Quiroga, J. A., Franck, J., Konstenius, M., et al. (2015) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2015.03.001 · Cited by 11
Self-citationZhang‐James, Y., Lloyd, D. R., James, M. L., Yang, L., Richards, J. B., & Faraone, S. V. (2019) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20190021 · Cited by 8
Self-citationADHS bei Jugendlichen und jungen Erwachsenen
Merkt, J., & Petermann, F. (2015) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747/a000239 · Cited by 8
ADHD and Risk-Taking Behavior: Associations, Mechanisms, and Interventions
Pollak, Y., Shoham, R., Scheres, A., & Dekkers, T. J. (2023) · Autism and child psychopathology series · doi:10.1007/978-3-031-41709-2_12 · Cited by 7
Więckiewicz, G., Stokłosa, I., Stokłosa, M., Więckiewicz, W., Gorczyca, P. W., & Gondek, T. M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1184023 · Cited by 7
Prevention of Health Risk Behaviors in ADHD Youth: Is ADHD Treatment Enough?
Schoenfelder, E. N., & Kollins, S. H. (2014) · The ADHD Report · doi:10.1521/adhd.2014.22.4.1 · Cited by 5
Self-citationSmoking cessation among people with mental illness: A South African perspective
Morar, T., & Robertson, L. J. (2022) · South African Family Practice · doi:10.4102/safp.v64i1.5489 · Cited by 4
ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas!
Naguy, A., PRIDMORE, S. A., Alwetayan, S., Elsori, D. H., & Alamiri, B. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4461 · Cited by 5
Attention Deficit Hyperactivity Disorder
Efron, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814180-9.00001-6 · Cited by 4
Correll, C. U., Starling, B. R., & Huß, M. (2021) · CNS Spectrums · doi:10.1017/s1092852921000341 · Cited by 4
Sweitzer, M. M., Lazzari, J., Lunsford‐Avery, J. R., McClernon, F. J., Kollins, S. H., Perkins, K. A., & Engelhard, M. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251344687 · Cited by 2
“…with ADHD who received continuous stimulant treatment were at lower risk for regular use of cigarettes compared to those not receiving treatment (Schoenfelder et al., 2014), suggesting the possibility that ameliorating underlying cognitive deficits via pharmacotherapy could help to mitigate…”
Self-citationYates, J. R., Broderick, M. R., Berling, K. L., Gieske, M. G., Osborn, E., Nelson, M. R., & Wright, M. R. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110970 · Cited by 3
Neurobiology of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Radonjić, N. V. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_33 · Cited by 2
Self-citationRemote monitoring of wide-ranging real-world changes in adults following ADHD medication initiation
Zhang, Y., Barnes, A. E., Veerakanjana, K., Denyer, H., Sankesara, H., Marriott, H., Rocks, P., Gerboni, G., Mortera, A., Müller, U., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03764-y · Cited by 2
“Some studies have also suggested that ADHD medication use reduces smoking [26] and alcohol use [27].”
Managing ADHD in children and young people: New insights
Greener, M. (2014) · British Journal of School Nursing · doi:10.12968/bjsn.2014.9.6.296
Pediatric Psychopharmacology: a Primer for the Treatment of Common Mental Health Conditions
Gleason, M. M. (2017) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-017-0081-0
“The associations among substance use and stimulants suggest ADHD treatment appears to protect against cigarette smoking and does not increase other substance use risk [22, 23].”
BackgroundWise, B. L. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Bruguera, E., Nieva, G., Valero, S., Comín, M., & Corrales, M. (2015)
Vito, J., Martin, A., Sood, A., & Chen, X. (2020) · Springer eBooks · doi:10.1007/978-3-030-33404-8_15
TDA/H - Trouble Déficit de l'Attention/Hyperactivité
Bange, F. (2014) · Dunod eBooks · doi:10.3917/dunod.bange.2014.01.0443
ADHD Medication and Substance-Related Problems
(2017) · American Research Journal of Addiction and Rehabilitation · doi:10.21694/2578-5508.17003
Individual differences in addiction
Yates, J. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90578-7.00013-x
Congiu, A., Vesentini, R., Locatelli, F., Zamboni, L., Giordano, R., Carli, S., Barbon, I., Casari, R., Melchiori, S., Campagnari, S., et al. (2023) · Medical Research Archives · doi:10.18103/mra.v11i10.4548
ADHD and physical health: comorbidity and risk factors
Reed, C. (2026) · ePrints Soton (University of Southampton) · doi:10.5258/soton/pg/t167
Metadata
- Authors
- Schoenfelder, E. N., Faraone, S. V., & Kollins, S. H.
- Affiliations
- Duke University (US)
- SUNY Upstate Medical University (US)
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2014-06-01
- Volume
- 133
- Issue
- 6
- Pages
- 1070-1080
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC4531271
- OpenAlex
- W2041726504
- Semantic Scholar
- e2e54a27f64e172d93ed7745b0f6adf0c6e8a583
- Cited by
- 55
- References
- 85
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 10 · 2022: 3 · 2021: 2 · 2020: 6 · 2019: 5 · 2018: 2 · 2017: 8 · 2016: 1 · 2015: 8 · 2014: 4
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- PEDIATRICS (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (K24DA023464)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, cigarette smoking, smoking risk, adolescent smoking, smoking prevention, treatment consistency
- MeSH terms
- Smoking Prevention, Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Cross-Sectional Studies, Female, Humans, Longitudinal Studies, Male, Risk, Smoking, Statistics as Topic, Tobacco Use Disorder, United States, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.